MedTrace Logo

Brain Imaging Study

NCT02439983 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2016-08-03

No results posted yet for this study

Summary

The study is designed to evaluate the effects of the proprietary nutritional supplement on cognition, mood, and brain imaging parameters following a relatively short period of treatment.

Conditions

  • Brain Health

Interventions

DIETARY_SUPPLEMENT

Proprietary Nutritional Supplement

2 capsules taken by mouth with morning and evening meals.

DIETARY_SUPPLEMENT

Placebo

2 capsules taken by mouth with morning and evening meals.

Sponsors & Collaborators

Principal Investigators

  • Deborah Yurgelun-Todd, Ph.D. · University of Utah

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02439983 on ClinicalTrials.gov